Spine Surgery Today has highlighted six stories of drugs and devices receiving government approval to keep your practice up-to-date.
Aesculap Implant Systems receives FDA clearance for new artificial disc
Aesculap Implant Systems recently announced its receipt of a letter of approval from the FDA for the commercial sale of its activL Artificial Disc for the treatment of one-level lumbar degenerative disc disease. Read more.
Oxford Performance receives FDA clearance for first 3-D–printed, load-bearing polymeric implant
Oxford Performance Materials has announced the FDA 510(k) clearance of the company’s SpineFab VBR implant system. Read more.
Captiva Spine receives clearance for cervical plate system and screw locking mechanism
Capitva Spine has announced its receipt of FDA 510(k) clearance to market an enhanced cervical plate system with a patented screw locking mechanism. Read more.
SpineGuard obtains regulatory clearance to sell PediGuard in China
SpineGuard recently announced it has received regulatory clearance to market and sell its Classic PediGuard line of products in China, according to a company press release. Read more.
Joimax receives FDA clearance for EndoLIF On-Cage implant
German company Joimax announced it has received 510(k) clearance from the FDA to market its Endoscopic Lumbar Interbody Fusion, or EndoLIF, On-Cage implant, according to a company press release. Read more.
InVivo Therapeutics receives Notice of Allowance for patent covering new scaffold system
InVivo Therapeutics recently announced it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent titled “Methods and Compositions for the Treatment of Open and Closed Wound Spinal Cord Injuries,” according to a press release. Read more.